Editas Medicine, Inc. Quarterly Marketable Securities, Current in USD from Q2 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Editas Medicine, Inc. quarterly Marketable Securities, Current history and growth rate from Q2 2017 to Q2 2024.
  • Editas Medicine, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $215M, a 1.67% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $215M +$3.52M +1.67% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $227M +$37.5M +19.8% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $199M -$3.29M -1.62% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $267M +$58.2M +27.8% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $211M -$72M -25.4% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $189M -$88.1M -31.7% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $203M -$93.6M -31.6% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $209M -$89M -29.9% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $283M +$10.4M +3.83% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $277M +$7.07M +2.61% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $296M +$33.9M +12.9% Dec 31, 2021 10-K 2023-02-22
Q3 2021 $298M +$82.2M +38.1% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $273M +$160M +142% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $270M +$88.3M +48.5% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $262M +$43.5M +19.9% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $216M -$12.1M -5.32% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $113M +$5.58M +5.2% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $182M -$1.99M -1.08% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $219M -$15.2M -6.5% Dec 31, 2019 10-K 2021-02-26
Q3 2019 $228M +$2.05M +0.91% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $107M -$105M -49.4% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $184M +$43M +30.5% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $234M +$51.7M +28.3% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $226M +$16.6M +7.96% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $212M +$31.5M +17.4% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $141M Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $183M Dec 31, 2017 10-K 2019-03-01
Q3 2017 $209M Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $181M Jun 30, 2017 10-Q 2017-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.